Shandong Sanyuan Biotechnology Co.,Ltd. (SHE:301206)
China flag China · Delayed Price · Currency is CNY
25.31
+0.18 (0.72%)
Oct 9, 2026, 3:04 PM CST

SHE:301206 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
685.43324.99160.29108.81489.04515.72
Short-Term Investments
901502,670---
Trading Asset Securities
621.43123.37---0.33
Cash & Short-Term Investments
1,397598.352,830108.81489.04516.05
Cash Growth
75.58%-78.86%2501.17%-77.75%-5.23%129.38%
Accounts Receivable
78.3485.5122.3780.9351.11141.36
Other Receivables
7.7137.55277.586.5512.8221.11
Receivables
86.06123.05399.9587.4863.94162.47
Inventory
201.82174.58142.71104.3396.77112.16
Other Current Assets
2.81,26815.0521.219.6214.95
Total Current Assets
1,6882,1643,388321.81669.37805.62
Property, Plant & Equipment
1,1791,1471,047987.27952.98770.61
Long-Term Investments
42.0442.1953.1856.0160.16-
Other Intangible Assets
72.6274.6746.4347.5848.7349.14
Long-Term Deferred Tax Assets
-----2.52
Other Long-Term Assets
1,499990.67270.333,3953,1396.27
Total Assets
4,4794,4194,8054,8084,8701,634

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
119.5595.85175.7208.57184.31542.47
Accrued Expenses
7.288.478.657.699.36.71
Current Income Taxes Payable
0-0--3.4
Current Unearned Revenue
4.2311.34.825.184.2211.43
Other Current Liabilities
102.322.3754.512.759.680.8
Total Current Liabilities
233.39117.99243.67224.2207.51564.81
Long-Term Unearned Revenue
1.92.443.514.590.860.99
Long-Term Deferred Tax Liabilities
54.0759.2966.8743.6140.7823.03
Total Liabilities
289.36179.71314.04272.4249.14588.83

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
202.33202.33202.33202.33202.33101.16
Additional Paid-In Capital
3,5183,5173,5183,5183,51872.13
Retained Earnings
530.23579.83788.87815.19900.84872.03
Treasury Stock
-60.69-60.69-17.6---
Comprehensive Income & Other
0.030.16----
Shareholders' Equity
4,1904,2394,4914,5354,6211,045
Total Liabilities & Equity
4,4794,4194,8054,8084,8701,634

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Cash (Debt)
1,397598.352,830108.81489.04516.05
Net Cash Growth
75.58%-78.86%2501.17%-77.75%-5.23%129.38%
Net Cash Per Share
6.973.0114.020.542.453.40
Filing Date Shares Outstanding
200200200.45202.33202.33202.33
Total Common Shares Outstanding
200200200.45202.33202.33151.74
Working Capital
1,4542,0463,14497.62461.86240.81
Book Value Per Share
20.9521.2022.4122.4122.846.89
Tangible Book Value
4,1174,1644,4454,4884,572996.19
Tangible Book Value Per Share
20.5920.8222.1722.1822.606.56
Buildings
235.5216.25215.87172.81138.8364.98
Machinery
1,1211,067994.69864.93786.97410.28
Construction In Progress
135.25137.1848.65103.69125.13357.27